Misplaced Pages

Itolizumab: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 19:46, 30 October 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'CAS_number_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiPr...← Previous edit Revision as of 09:49, 31 October 2011 edit undoBeetstra (talk | contribs)Edit filter managers, Administrators172,084 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'CAS_number').Next edit →
Line 33: Line 33:
| ChemSpiderID = NA | ChemSpiderID = NA
| CAS_number_Ref = {{cascite|correct|??}} | CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 1116433-11-4 | CAS_number = <!-- blanked - oldvalue: 1116433-11-4 -->
| ATC_prefix = none | ATC_prefix = none
| ATC_suffix = | ATC_suffix =

Revision as of 09:49, 31 October 2011

Pharmaceutical compound
Itolizumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized
TargetCD6
Clinical data
ATC code
  • none
Identifiers
ChemSpider
UNII
  (what is this?)  (verify)

Itolizumab is an immunomodulator. It binds to CD6.

References

  1. World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103" (PDF). WHO Drug Information.
Monoclonal antibodies for the immune system
Immune system
Human
Mouse
Chimeric
Humanized

Immune activation: Dostarlimab
Other: Ibalizumab

Chimeric + humanized
Interleukin
Human
Humanized
Veterinary
Inflammatory lesions
Mouse


Stub icon

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it.

Categories:
Itolizumab: Difference between revisions Add topic